Laboratorio Farmaceu...
BIT:ERFO
1,25
+ €0,02 (1,63%)
1,25
+€0,02 (1,63%)
End-of-day quote: 03/10/2026

Laboratorio Farmaceutico Erfo S.p.A. Stock Value

The analyst rating for BIT:ERFO is currently Buy.
Buy
Buy

Laboratorio Farmaceutico Erfo S.p.A. Company Info

EPS Growth 5Y
-29,29%
Market Cap
€0,01 B
Long-Term Debt
€0,00 B
Annual earnings
03/31/2026
Dividend
€0,00
Dividend Yield
0,00%
Founded
2013
Industry
Country
ISIN Number

Analyst Price Target

€2,08
66.4%
66.4
Last Update: 03/09/2026
Analysts: 1

Highest Price Target €2,08

Average Price Target €2,08

Lowest Price Target €2,08

In the last five quarters, Laboratorio Farmaceutico Erfo S.p.A.’s Price Target has risen from €1,04 to €1,47 - a 41,35% increase. One analysts predict that Laboratorio Farmaceutico Erfo S.p.A.’s share price will increase in the coming year, reaching €2,08. This would represent an increase of 66,40%.

Top growth stocks in the health care sector (5Y.)

What does Laboratorio Farmaceutico Erfo S.p.A. do?

Laboratorio Farmaceutico Erfo S.p.A. specializes in the formulation, production, and commercialization of nutraceutical products. Through continuous Research and Development activities, conducted both internally and in collaboration with the Università Campus Bio-Medico di Roma, Università degli Studi di Messina, and the Consiglio Nazionale delle Ricerche, the company is able to market products that align with market trends and consumer needs. Business Segments The company’s business is organi...
×